Patients' self-assessment versus investigators' evaluation in a phase III trial in non-castrate metastatic prostate cancer (GETUG-AFU 15)

European Journal of Cancer

Volumn 50, Issue 5, 2014, Pages 953-962

  Gravis, Gwenaelle ^a   Marino, Patricia ^a,b   Joly, Florence ^c   Oudard, Stéphane ^d   Priou, Franck ^e   Esterni, Benjamin ^a   Latorzeff, Igor ^f   Delva, Remy ^g   Krakowski, Ivan ^h   Laguerre, Brigitte ⁱ   Rolland, Fréderic ^j   Théodore, Christine ^k   Deplanque, Gael ^l   Ferrero, Jean Marc ^m   Pouessel, Damien ⁿ   Mourey, Loïc ^o   Beuzeboc, Philippe ^p   Zanetta, Sylvie ^q   Habibian, Muriel ^r   Berdah, Jean François ^s   Dauba, Jerome ^t   Baciuchka, Marjorie ^u   Platini, Christian ^v   Linassier, Claude ^w   Labourey, Jean Luc ^x   Machiels, Jean Pascal ^y   El Kouri, Claude ^z   Ravaud, Alain ^aa   Suc, Etienne ^ab   Eymard, Jean Christophe ^ac   Hasbini, Ali ^ab   Bousquet, Guilhem ^ad   Soulie, Michel ^ae   Fizazi, Karim ^af   more..

^a INSTITUT PAOLI CALMETTES   (France)

^b AIX MARSEILLE UNIV   (France)

^c CHU CÔTE DE NACRE   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e Medical Oncology   (France)

^f CLINIQUE PASTEUR   (France)

^g CENTRE PAUL PAPIN   (France)

^h CENTRE ALEXIS VAUTRIN   (France)

ⁱ CENTRE EUGÈNE MARQUIS   (France)

^j CENTRE RENÉ GAUDUCHEAU   (France)

^k FOCH HOSPITAL   (France)

^l SAINT JOSEPH HOSPITAL   (France)

^m CENTRE ANTOINE LACASSAGNE   (France)

ⁿ CENTRE VAL D AURELLE   (France)

^o INSTITUT CLAUDIUS REGAUD   (France)

^p INSTITUT CURIE   (France)

^q CENTRE GEORGES FRANÇOIS LECLERC   (France)

^r UNICANCER   (France)

^s Medical Oncology   (France)

^t Hôpital Layné   (France)

^u TIMONE HOSPITAL   (France)

^v Centre Régional Hospitalier Metz Thionville   (France)

^w CHU BRETONNEAU   (France)

^x DUPUYTREN UNIVERSITY HOSPITAL   (France)

^y CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^z Centre Catherine de Sienne   (France)

^aa HÔPITAL SAINT ANDRÉ   (France)

^ab Clinique Saint Jean Languedoc   (France)

^ac INSTITUT JEAN GODINOT   (France)

^ad SAINT LOUIS HOSPITAL   (France)

^ae CHU RANGUEIL   (France)

^af INSTITUT GUSTAVE ROUSSY   (France)

more..

Author keywords

Docetaxel; Non castrate; Patient reported outcome; Phase III; Prostate; Toxicity

Indexed keywords

ANTIANDROGEN; DOCETAXEL;

ADULT; AGED; ALOPECIA; ANDROGEN DEPRIVATION THERAPY; ANOREXIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CONSTIPATION; DRUG INTOXICATION; EDEMA; FATIGUE; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MYALGIA; NAIL DISEASE; NAUSEA; NEUROPATHY; NON CASTRATE METASTATIC PROSTATE CANCER; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CANCER; SELF EVALUATION; SELF REPORT; SEXUAL DYSFUNCTION; SKIN TOXICITY; SYMPTOM; TASTE DISORDER; URINARY DYSFUNCTION; VERY ELDERLY; VOMITING;

DOCETAXEL; NON-CASTRATE; PATIENT REPORTED OUTCOME; PHASE III; PROSTATE; TOXICITY;

ADULT; AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARTHRALGIA; FATIGUE; HOT FLASHES; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICIAN-PATIENT RELATIONS; PROSTATIC NEOPLASMS; QUESTIONNAIRES; SELF-ASSESSMENT; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TAXOIDS; WEIGHT GAIN; WEIGHT LOSS;

EID: 84896730407     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.11.034     Document Type: Article

References (30)

1. A. Trotti, A.D. Colevas, A. Setser, and E. Basch Patient-reported outcomes and the evolution of adverse event reporting in oncology J Clin Oncol 25 32 2007 5121 5127
2. E.A. Laugsand, M.A. Sprangers, K. Bjordal, F. Skorpen, S. Kaasa, and P. Klepstad Health care providers underestimate symptom intensities of cancer patients: a multicenter European study Health Qual Life Outcomes 8 2010 104
3. E. Basch, A. Iasonos, and T. McDonough et al. Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study Lancet Oncol 7 11 2006 903 909
4. G. Macquart-Moulin, P. Viens, and M.L. Bouscary et al. Discordance between physicians' estimations and breast cancer patients' self-assessment of side-effects of chemotherapy: an issue for quality of care Br J Cancer 76 12 1997 1640 1645
5. L.J. Fallowfield Treatment decision-making in breast cancer: the patient-doctor relationship Breast Cancer Res Treat 112 Suppl. 1 2008 5 13
6. G. Velikova, L. Booth, and A.B. Smith et al. Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial J Clin Oncol 22 4 2004 714 724
7. E. Basch, X. Jia, and G. Heller et al. Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes J Natl Cancer Inst 101 23 2009 1624 1632
8. E. Basch The missing voice of patients in drug-safety reporting N Engl J Med 362 10 2010 865 869
9. D.W. Bruner Should patient-reported outcomes be mandatory for toxicity reporting in cancer clinical trials? J Clin Oncol 25 34 2007 5345 5347
10. E.M. Basch, B.B. Reeve, and C.S. Cleeland et al. Development of the patient-reported version of the common terminology criteria for adverse events (PRO-CTCAE) J Clin Oncol 28 15-suppl (May 20 Supplement) 2010 [ASCO Annual Meeting Proceedings (Post-Meeting Edition)]
11. G. Gravis, K. Fizazi, and F. Joly et al. Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial Lancet Oncol 14 2013 149 158
12. J.R. Landis, and G.G. Koch The measurement of observer agreement for categorical data Biometrics 33 1 1977 159 174
13. D.V. Cicchetti, and A.R. Feinstein High agreement but low kappa: II. Resolving the paradoxes J Clin Epidemiol 43 6 1990 551 558
14. P. Studenic, H. Radner, J.S. Smolen, and D. Aletaha Discrepancies between patients and physicians in their perceptions of rheumatoid arthritis disease activity Arthritis Rheum 64 9 2012 2814 2823
15. I. Yalcin, and L. Viktrup Comparison of physician and patient assessments of incontinence severity and improvement Int Urogynecol J Pelvic Floor Dysfunct 18 11 2007 1291 1295
16. M. Zimmerman, J.B. McGlinchey, M.A. Posternak, M. Friedman, D. Boerescu, and N. Attiullah Discordance between self-reported symptom severity and psychosocial functioning ratings in depressed outpatients: implications for how remission from depression should be defined Psychiatry Res 141 2 2006 185 191
17. S.E. Ward, N. Goldberg, and V. Miller-McCauley et al. Patient-related barriers to management of cancer pain Pain 52 3 1993 319 324
18. K.R. Sepucha, J.K. Belkora, S. Mutchnick, and L.J. Esserman Consultation planning to help breast cancer patients prepare for medical consultations: effect on communication and satisfaction for patients and physicians J Clin Oncol 20 11 2002 2695 2700
19. J.W. Robinson, S. Moritz, and T. Fung Meta-analysis of rates of erectile function after treatment of localized prostate carcinoma Int J Radiat Oncol Biol Phys 54 4 2002 1063 1068
20. M.S. Litwin, D.P. Lubeck, J.M. Henning, and P.R. Carroll Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: results of the CaPSURE database J Urol 159 6 1998 1988 1992
21. E. Basch Patient-reported outcomes in drug safety evaluation Ann Oncol 20 12 2009 1905 1906
22. J.C. Weeks, P.J. Catalano, and A. Cronin et al. Patients' expectations about effects of chemotherapy for advanced cancer N Engl J Med 367 17 2012 1616 1625
23. P.A. Parker, W.F. Baile, C. de Moor, R. Lenzi, A.P. Kudelka, and L. Cohen Breaking bad news about cancer: patients' preferences for communication J Clin Oncol 19 7 2001 2049 2056
24. G. Gravis, C. Protiere, and F. Eisinger et al. Full access to medical records does not modify anxiety in cancer patients: results of a randomized study Cancer 117 20 2011 4796 4804
25. E.K. Fromme, K.M. Eilers, M. Mori, Y.C. Hsieh, and T.M. Beer How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30 J Clin Oncol 22 17 2004 3485 3490
26. G. van Andel, A. Bottomley, and S.D. Fossa et al. An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer Eur J Cancer 44 16 2008 2418 2424
27. I.F. Tannock, R. de Wit, and W.R. Berry et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer N Engl J Med 351 15 2004 1502 1512
28. K. Gondek, P.P. Sagnier, K. Gilchrist, and J.M. Woolley Current status of patient-reported outcomes in industry-sponsored oncology clinical trials and product labels J Clin Oncol 25 32 2007 5087 5093
29. E.P. Rock, D.L. Kennedy, M.H. Furness, W.F. Pierce, R. Pazdur, and L.B. Burke Patient-reported outcomes supporting anticancer product approvals J Clin Oncol 25 32 2007 5094 5099
30. M. Cirillo, M. Venturini, L. Ciccarelli, F. Coati, O. Bortolami, and G. Verlato Clinician versus nurse symptom reporting using the National Cancer Institute-Common Terminology Criteria for Adverse Events during chemotherapy: results of a comparison based on patient's self-reported questionnaire Ann Oncol 20 12 2009 1929 1935